Roche has received FDA clearance for its Accu-Chek Nano SmartView system for monitoring blood glucose. The device, which is targeted for U.S. market launch in the first half of this year, is designed to allow diabetes patients to create personalized test alerts and meal markers, as well as compute their average glucose levels.

Related Summaries